CTO: in Radial Access with Similar Results to Femoral

Courtesy of Dr. Carlos Fava.

One of the characteristics of chronic total occlusion (CTO) is the use of two access routes: femoral and radial. The radial approach is safer, but it has not been thoroughly analyzed in this type of PCI.

Successful CTO Reduces Local and Remote Residual IschemiaThe study looked at 3709 patients undergoing left main percutaneous coronary intervention (PCI) for CTO. Only 2157 patients were accessed via femoral approach (58.1%), 728 via radial approach (19.6%), and 824 via both femoral and radial approach (22.2%). The use of radial approach increased over time.

 

Mean age was 65, and most patients were men. Those undergoing radial access or femoral and radial access PCI were younger, had more acute coronary syndrome, and less risk factors, peripheral coronary heart disease, or prior revascularization procedures.



Read also: Asymptomatic Coronary Artery Disease, Silent Ischemia: A Cardiologist’s Headache.


J-CTO score (Multicenter CTO Registry in Japan) was lower in radial access patients (2.1±1.4 vs. 2.6±1.3 vs. 2.5±1.3; p < 0.001).

 

Antegrade dissection re-entry was less used in radial access patients, while retrograde techniques were higher.

 

Technical and procedural success was similar for the three strategies.


Read also: Abluminal Sirolimus and luminal CD34 antibody layer: Is COMBO the Future of Stents?


As regards in-hospital complications, there were no differences in mortality or MACE, but there was a higher rate of bleeding in the femoral approach group.

 

Conclusion

The use of radial access is no the rise when it comes to PCI for CTO, seeing as it is associated with less major bleeding, compared with the use of the femoral approach alone.

 

Courtesy of Dr. Carlos Fava.

 

Título original: Procedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach. Insights From an International Chronic Total Occlusion Registry.

Reference: Peter Tajti, et al J Am Coll Cardiol Intv 2019;12:346–58.



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....